Effects of Selected OATP and/or ABC Transporter Inhibitors on the Brain and Whole-Body Distribution of Glyburide

No abstract is available for this paper.

• Publication year

  2013

• Venue

  AAPS Journal

• Publication date

  2013-08-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1208/s12248-013-9514-2PMID 23907487PMCID PMC3787228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset.

  2013cited by this paper
• camptothecin analogs co-operative drug efflux system that restricts the brain entry of Abcc4 together with Abcb1 and Abcg2 form a robust

  2013cited by this paper
• Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues

  2013cited by this paper
• Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects

  2013cited by this paper
• Saturable Active Efflux by P-Glycoprotein and Breast Cancer Resistance Protein at the Blood-Brain Barrier Leads to Nonlinear Distribution of Elacridar to the Central Nervous System

  2013cited by this paper
• PET Imaging–Based Evaluation of Hepatobiliary Transport in Humans with (15R)-11C-TIC-Me

  2012cited by this paper
• Sulfonylurea receptor 1 in central nervous system injury: a focused review

  2012cited by this paper
• Quantitative Proteomics of Transporter Expression in Brain Capillary Endothelial Cells Isolated from P-Glycoprotein (P-gp), Breast Cancer Resistance Protein (Bcrp), and P-gp/Bcrp Knockout Mice

  2012cited by this paper
• Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions

  2012cited by this paper
• Steroid hormones specifically modify the activity of organic anion transporting polypeptides.

  2012cited by this paper
• Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2.

  2012cited by this paper
• Cyclosporine A- and Tacrolimus-Mediated Inhibition of CYP3A4 and CYP3A5 In Vitro

  2012cited by this paper
• The expression and function of organic anion transporting polypeptides in normal tissues and in cancer.

  2012cited by this paper
• Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high‐risk population

  2012cited by this paper
• TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis

  2012cited by this paper
• Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3.

  2011cited by this paper
• Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist

  2011cited by this paper
• Inactivation of Multidrug Resistance Proteins Disrupts Both Cellular Extrusion and Intracellular Degradation of cAMP

  2011cited by this paper
• Role of Organic Anion-Transporting Polypeptides for Cellular Mesalazine (5-Aminosalicylic Acid) Uptake

  2011cited by this paper
• Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.

  2011cited by this paper
• Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters

  2011cited by this paper
• Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin.

  2010cited by this paper
• Hepatic Uptake of the Magnetic Resonance Imaging Contrast Agent Gd-EOB-DTPA: Role of Human Organic Anion Transporters

  2010cited by this paper
• Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).

  2010cited by this paper
• Contributions of human cytochrome P450 enzymes to glyburide metabolism

  2010cited by this paper
• Transplacental Pharmacokinetics of Glyburide, Rhodamine 123, and BODIPY FL Prazosin: Effect of Drug Efflux Transporters and Lipid Solubility

  2009cited by this paper
• Elucidating Rifampin's Inducing and Inhibiting Effects on Glyburide Pharmacokinetics and Blood Glucose in Healthy Volunteers: Unmasking the Differential Effects of Enzyme Induction and Transporter Inhibition for a Drug and Its Primary Metabolite

  2009cited by this paper
• Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies.

  2008cited by this paper
• Effect of albumin on transplacental transfer and distribution of rosiglitazone and glyburide

  2008cited by this paper
• Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta.

  2008cited by this paper
• In Situ Mouse Carotid Perfusion Model: Glucose and Cholesterol Transport in the Eye and Brain

  2008cited by this paper
• The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta.

  2008cited by this paper
• P-Glycoprotein and Breast Cancer Resistance Protein: Two Dominant Transporters Working Together in Limiting the Brain Penetration of Topotecan

  2007cited by this paper
• The Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Fetal Distribution of Glyburide in the Pregnant Mouse: An Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study

  2007cited by this paper
• Transport of glyburide by placental ABC transporters: implications in fetal drug exposure.

  2006cited by this paper
• Organic anion transporting polypeptide 2B1 is a high‐affinity transporter for atorvastatin and is expressed in the human heart

  2006cited by this paper
• PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISM

  2006cited by this paper
• The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients.

  2005cited by this paper
• CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B

  2005cited by this paper
• Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies.

  2005cited by this paper
• Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.

  2004cited by this paper
• Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.

  2004cited by this paper
• In silico prediction of blood-brain barrier permeation.

  2003cited by this paper
• Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver

  2002cited by this paper
• P-glycoprotein inhibition by glibenclamide and related compounds

  1999cited by this paper
• Pharmacokinetic disposition of 14C‐glyburide in patients with varying renal function

  1986cited by this paper

• Imaging the impact of sex and age on OATP function in humans: Consequences for whole-body pharmacokinetics and liver exposure

  2025cites this paper
• Assessment of intranasal permeability and pharmacological activity of glyburide-loaded nanosuspension formulation for Alzheimer's disease.

  2025cites this paper
• Imagerie moléculaire pour l’étude des répercussions pharmacocinétiques des transporteurs hépatiques

  2025cites this paper
• Strategies to Improve Pharmacokinetics of Hepatic Uptake Transporter Substrates.

  2025cites this paper
• A Data Mining Approach on Polypharmacy and Drug-drug Interactions of Common Diabetes Medications.

  2025cites this paper
• Nanotechnology approaches to drug delivery for the treatment of ischemic stroke

  2024cites this paper
• Rat PermQ: A permeability- and perfusion-based physiologically based pharmacokinetic model for improved prediction of drug concentration-time profiles in rat.

  2024cites this paper
• The NLRP3 inflammasome: A central player in multiple sclerosis.

  2024cites this paper
• Brain‐Targeted 9‐Phenanthrol‐Loaded Lipid Nanoparticle Prevents Brain Edema after Cerebral Ischemia‐Reperfusion Injury by Inhibiting the Trpm4 Channel in Mice

  2024cites this paper
• Uptake Transporters at the Blood–Brain Barrier and Their Role in Brain Drug Disposition

  2023cites this paper
• Impact of protein deficient diet on the pharmacokinetics of glibenclamide in a model of malnutrition in rats

  2023cites this paper
• Isotopic Radiolabeling of the Antiretroviral Drug [18F]Dolutegravir for Pharmacokinetic PET Imaging

  2022cites this paper
• Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging

  2022cites this paper
• [11C]glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human liver and whole-body.

  2022cites this paper
• Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue

  2022cites this paper
• Mechanical Disturbance of Osteoclasts Induces ATP Release That Leads to Protein Synthesis in Skeletal Muscle through an Akt-mTOR Signaling Pathway

  2022cites this paper
• A permeability‐ and perfusion‐based PBPK model for improved prediction of concentration‐time profiles

  2022cites this paper
• Brain Targeting, Antioxidant Polymeric Nanoparticles for Stroke Drug Delivery and Therapy.

  2022cites this paper
• Long term delivery of glibenclamide from in situ forming microparticles for the treatment of ischemic stroke

  2021cites this paper
• Radiolabeling and brain penetration of [11 C]VU0071063, a ligand of type 1 sulfonylurea receptors (SUR1) for PET imaging.

  2021cites this paper
• New Horizons for the Roles and Association of APE1/Ref-1 and ABCA1 in Atherosclerosis

  2021cites this paper
• Sulfonylureas target the neurovascular response to decrease Alzheimer’s pathology

  2021cites this paper
• Recent advances in nanomedicines for the treatment of ischemic stroke

  2020cites this paper
• Retinal and choroidal cancers: Blood-retinal barriers considerations in ocular chemotherapy

  2020cites this paper
• Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans.

  2020cites this paper
• Recent progress in in vivo phenotyping technologies for better prediction of transporter-mediated drug-drug interactions.

  2020cites this paper
• Use of imaging to assess the activity of hepatic transporters

  2020cites this paper
• Interrupted aza-Wittig reactions using iminophosphoranes to synthesize 11C-carbonyls.

  2020cites this paper
• Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc]mebrofenin Imaging in Rats

  2020cites this paper
• Dysregulation of solute carrier transporters in malaria‐infected pregnant mice

  2019cites this paper
• Molecular imaging of β-cells: diabetes and beyond.

  2019cites this paper
• Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells.

  2019cites this paper
• Current Research Method in Transporter Study.

  2019cites this paper
• Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles

  2019influential citation
• Effect of Rifampicin on the Distribution of [11C]Erlotinib to the Liver, a Translational PET Study in Humans and in Mice.

  2018cites this paper
• Pharmacokinetics, Tissue Distribution and Excretion of a Novel Diuretic (PU-48) in Rats

  2018cites this paper
• Vegetative polysaccharides: new target and direction of clinical use

  2018cites this paper
• Imaging techniques to study drug transporter function in vivo.

  2018cites this paper
• Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles

  2018cites this paper
• Renal Drug Transporters and Drug Interactions

  2017cites this paper
• Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus.

  2017cites this paper
• Unmasking the Role of Uptake Transporters for Digoxin Uptake Across the Barriers of the Central Nervous System in Rat

  2017cites this paper
• Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice

  2017cites this paper
• Imaging Probes and Modalities for the Study of Solute Carrier O (SLCO)-Transport Function In Vivo.

  2017cites this paper
• Anthelminthic activity of glibenclamide on secondary cystic echinococcosis in mice

  2017cites this paper
• Use of PET Imaging to Evaluate Transporter‐Mediated Drug‐Drug Interactions

  2016cites this paper
• Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates.

  2016cites this paper
• Validation of a simple HPLC-UV method for rifampicin determination in plasma: Application to the study of rifampicin arteriovenous concentration gradient.

  2016cites this paper
• Novel No-Wash Luminogenic Probes for the Detection of Transporter Uptake Activity.

  2016cites this paper
• PET Tracers To Study Clinically Relevant Hepatic Transporters.

  2015cites this paper
• Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity

  2015cites this paper
• Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents

  2015influential citation
• Molecular Imaging of Membrane Transporters’ Activity in Cancer: a Picture is Worth a Thousand Tubes

  2015influential citation
• OATP Transporters : Potential Targets for Enhancing Organ and Tissue Specific Drug Delivery

  2014cites this paper
• Using Positron Emission Tomography to Study Transporter-Mediated Drug–Drug Interactions in Tissues

  2014cites this paper
• Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins.

  2014cites this paper
• Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

  2014cites this paper
• A Philosophy for CNS Radiotracer Design

  2014cites this paper
• [Methods for the study of drug transporters].

  2014cites this paper